Trades on 3 secondary markets

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company (Nasdaq: EIKN) founded in 2019 and headquartered in Millbrae, California, with additional offices in New York and Jersey City. Eikon built a proprietary drug-discovery platform around single-molecule live-cell imaging, applying super-resolution fluor

minimal 10.8 / 100 0 APIs View provider profile →

Company Biotech Biopharmaceutical Drug Discovery Live-Cell Imaging Super-Resolution Microscopy

Eikon Therapeutics is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, EquityZen.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.